Advertisements

Indivior shares dive after Dr Reddy"s gets FDA approval for generic

Indivior shares dive after Dr Reddy"s gets FDA approval for generic.....»»

Category: global-financeSource: reutersJun 15th, 2018

Dr Reddy#39;s Labs announces generic version of Straterra in US market

Dr Reddy#39;s Labs announces generic version of Straterra in US market.....»»

Category: topSource: moneycontrolOct 31st, 2018

Teva to hold Indivior generic drug launch pending US ruling

Teva to hold Indivior generic drug launch pending US ruling.....»»

Category: topSource: moneycontrolSep 12th, 2018

Indivior says U.S. court rules against generic rival"s appeal

Indivior says U.S. court rules against generic rival"s appeal.....»»

Category: global-financeSource: reutersJul 31st, 2018

U.S. court expedites Indivior rival Dr. Reddy"s appeal to re-launch generic drug

U.S. court expedites Indivior rival Dr. Reddy"s appeal to re-launch generic drug.....»»

Category: global-financeSource: reutersJul 30th, 2018

US court restrains DRL"s sale of Suboxone anti-opioid copy - The Hindu

US court restrains DRL"s sale of Suboxone anti-opioid copy - The Hindu.....»»

Category: topSource: googlenewsJul 14th, 2018

US court prevents Dr Reddy"s from launching opioid treatment drug Suboxone - The Hindu

US court prevents Dr Reddy"s from launching opioid treatment drug Suboxone - The Hindu.....»»

Category: topSource: googlenewsJul 14th, 2018

Indivior wins preliminary injunction against generic rival

Indivior wins preliminary injunction against generic rival.....»»

Category: global-financeSource: reutersJul 14th, 2018

Dr.Reddy’s to sell generic version of opioid addiction treatment Suboxone in U.S.

Dr.Reddy’s to sell generic version of opioid addiction treatment Suboxone in U.S......»»

Category: topSource: the-hinduJun 15th, 2018

Biocon share price surges 15% on FDA nod for generic cancer drug

Biocon share price surges 15% on FDA nod for generic cancer drug.....»»

Category: marketsSource: thehindubusinesslineDec 4th, 2017

Biocon rallies over 14% on FDA approval for biosimilar version of Herceptin

Biocon rallies over 14% on FDA approval for biosimilar version of Herceptin.....»»

Category: marketsSource: thehindubusinesslineDec 4th, 2017

Biocon hits record high on EMA approval for cancer drugs

Biocon hits record high on EMA approval for cancer drugs.....»»

Category: marketsSource: thehindubusinesslineDec 1st, 2017

Glenmark gets USFDA nod for contraceptive drug; shares up 0.4%

Glenmark gets USFDA nod for contraceptive drug; shares up 0.4%.....»»

Category: marketsSource: thehindubusinesslineNov 22nd, 2017

Lupin surges 3% on USFDA approval for hypertension drug

Lupin surges 3% on USFDA approval for hypertension drug.....»»

Category: marketsSource: thehindubusinesslineOct 10th, 2017

Mylan surges, Teva slumps after FDA approves Copaxone copy

Mylan surges, Teva slumps after FDA approves Copaxone copy.....»»

Category: global-financeSource: reutersOct 5th, 2017

Mylan surges, Teva slumps after FDA approves Copaxone copy

Mylan surges, Teva slumps after FDA approves Copaxone copy.....»»

Category: marketsSource: sifyOct 5th, 2017

Natco Pharma shares surge on FDA nod to Mylan’s drug

Natco Pharma shares surge on FDA nod to Mylan’s drug.....»»

Category: topSource: livemintOct 4th, 2017

Natco Pharma shares jump 20% as partner Mylan gets USFDA nod for multiple sclerosis drug

Natco Pharma shares jump 20% as partner Mylan gets USFDA nod for multiple sclerosis drug.....»»

Category: economySource: livemintOct 4th, 2017

Natco Pharma spurts 20% on USFDA nod for multiple sclerosis drug

Natco Pharma spurts 20% on USFDA nod for multiple sclerosis drug.....»»

Category: marketsSource: thehindubusinesslineOct 4th, 2017

Dr Reddy"s Labs jumps over 3%

Dr Reddy"s Labs jumps over 3%.....»»

Category: marketsSource: thehindubusinesslineOct 3rd, 2017

Indivior files lawsuits against Suboxone generic rivals

Indivior files lawsuits against Suboxone generic rivals.....»»

Category: global-financeSource: reutersSep 15th, 2017